Reports for HYDROCHLOROTHIAZIDE
Ingredient
HYDROCHLOROTHIAZIDE
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| PMS-IRBESARTAN-HCTZ | 25MG 300MG | TABLET | Resolved | 2023-10-02 | 2023-12-22 | 205611 |
| PMS-IRBESARTAN-HCTZ | 25MG 300MG | TABLET | Actual shortage | 2024-02-07 | 2024-04-29 | 218776 |
| APO-OLMESARTAN/HCTZ | 12.5MG 20MG | TABLET | Resolved | 2017-07-25 | 2018-04-23 | 16900 |
| APO-OLMESARTAN/HCTZ | 12.5MG 20MG | TABLET | Resolved | 2018-07-04 | 2018-11-22 | 54303 |
| APO-OLMESARTAN/HCTZ | 12.5MG 20MG | TABLET | Resolved | 2018-12-27 | 2020-07-11 | 70532 |
| APO-OLMESARTAN/HCTZ | 12.5MG 20MG | TABLET | Anticipated shortage | 2024-01-19 | 2024-01-19 | 216720 |
| APO-OLMESARTAN/HCTZ | 12.5MG 40MG | TABLET | Resolved | 2017-07-25 | 2018-04-23 | 16905 |
| APO-OLMESARTAN/HCTZ | 12.5MG 40MG | TABLET | Resolved | 2018-12-12 | 2020-07-11 | 69452 |
| APO-OLMESARTAN/HCTZ | 12.5MG 40MG | TABLET | Anticipated shortage | 2024-01-19 | 2024-01-19 | 216723 |
| APO-OLMESARTAN/HCTZ | 25MG 40MG | TABLET | Resolved | 2017-07-25 | 2017-11-17 | 16895 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-02-23 | 2018-07-17 | 40763 | ||
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-09-07 | 2018-09-15 | 60548 | ||
| ACT CANDESARTAN/HCT | Discontinued | 2018-10-19 | 2018-10-19 | 65050 | ||
| ACT CANDESARTAN/HCT | Discontinued | 2018-10-19 | 2018-10-19 | 65052 | ||
| ACT IRBESARTAN/HCT | Discontinued | 2018-10-19 | 2018-10-19 | 65068 | ||
| ACT IRBESARTAN/HCT | Discontinued | 2018-10-19 | 2018-10-19 | 65071 | ||
| ACT IRBESARTAN/HCT | Discontinued | 2018-10-19 | 2018-10-19 | 65074 | ||
| RAMIPRIL-HCTZ | Discontinued | 2018-12-21 | 2018-12-22 | 70392 | ||
| APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71044 | ||
| APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71048 |